Skip to main content

Málstofa Lífvísindaseturs: IDH2-mediated glutamine dependency in breast

Málstofa Lífvísindaseturs: IDH2-mediated glutamine dependency in breast - á vefsíðu Háskóla Íslands
Hvenær 
23. janúar 2020 11:40 til 12:30
Hvar 

Læknagarður

stofa 201

Nánar 
Aðgangur ókeypis

Málstofa Lífvísindaseturs Háskóla Íslands fimmtudaginn 23. janúar kl. 11:40 í Læknagarði, stofu 201

Fyrirlesari: Sigurður Trausti Karvelsson, doktorsnemi á rannsóknastofu í Kerfislíffræði, leiðbeinendur eru Óttar Rolfsson prófessor og Steinn Guðmundsson dósent, Læknadeild Háskóla Íslands

Titill: IDH2-mediated glutamine dependency in breast epithelial cells: Implications for drug resistance.

Inngangur: Epithelial to mesenchymal transition (EMT) is a fundamental developmental process with strong implications in cancer progression. Understanding the metabolic alterations associated with EMT may open new avenues of treatment and prevention.

Aðferðir: We have utilized  13C-carbon analogs of glucose and glutamine and network analysis to specifically examine differences in internal metabolic fluxes within both central carbon and lipid metabolism following EMT in breast epithelial cells.

Niðurstöður: Higher glycolytic rates and glutamine-dependent glutathione generation were observed pre-EMT, whereas higher TCA-cycle flux fueled by reductive carboxylation of glutamine to lipid biosynthesis is the post-EMT phenotype along with significantly lowered glutathione biosynthesis. Furthermore, the inhibition of mitochondrial NADP-dependent isocitrate dehydrogenase (IDH2) a key enzyme in reductive carboxylation, affected both proliferation and metabolic activity of cells both pre- and post-EMT. Finally, we compared the resulting metabolic phenotypes to the NCI-60 Human Tumor Cell line panel and show that glutathione concentration is significantly associated with the response to several drugs, which we then confirmed in our cell model.

Erindið verður flutt á ensku og eru allir velkomnir.

Sigurður Trausti Karvelsson

Málstofa Lífvísindaseturs: IDH2-mediated glutamine dependency in breast